F. Hanisch

Cutting it close: CRISPR-associated endoribonuclease structure and function

Myasthenia Gravis

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

Myasthenia gravis

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

Metformin Activates AMP Kinase through Inhibition of AMP Deaminase

AMPK: a nutrient and energy sensor that maintains energy homeostasis

MuSK-antibody positive myasthenia gravis: Questions from the clinic

Myasthenia gravis: subgroup classification and therapeutic strategies

EFNS/ENS Guidelines for the treatment of ocular myasthenia

Okuläre Beteiligung bei MuSK-Antikörper-positiver Myasthenia gravis

AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance

„Seronegative“ Myasthenie mit Antikörpern gegen die muskelspezifische Tyrosin-Kinase